IRIS
TUFANO, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.615
EU - Europa 1.076
AS - Asia 730
AF - Africa 73
SA - Sud America 10
Continente sconosciuto - Info sul continente non disponibili 2
Totale 3.506
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.589
SG - Singapore 542
DE - Germania 348
IT - Italia 348
CN - Cina 174
NL - Olanda 117
CI - Costa d'Avorio 70
FI - Finlandia 65
IE - Irlanda 62
UA - Ucraina 41
ES - Italia 28
CA - Canada 24
FR - Francia 21
GB - Regno Unito 16
CH - Svizzera 11
BG - Bulgaria 6
IN - India 6
BR - Brasile 4
AR - Argentina 3
BD - Bangladesh 2
BE - Belgio 2
CO - Colombia 2
CZ - Repubblica Ceca 2
MA - Marocco 2
MK - Macedonia 2
MX - Messico 2
PL - Polonia 2
SE - Svezia 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BJ - Benin 1
EU - Europa 1
GR - Grecia 1
JP - Giappone 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
TH - Thailandia 1
TW - Taiwan 1
Totale 3.506
Salva come PNG Salva come JPEG
Città #
Singapore 445
Chandler 213
Santa Clara 125
Millbury 124
Amsterdam 108
Naples 103
Princeton 67
Ashburn 59
Boston 52
Beijing 47
Nanjing 47
Lawrence 41
Krefeld 38
Boardman 32
Wilmington 32
Des Moines 31
Jacksonville 27
Munich 23
Napoli 22
Ottawa 22
Castellón 18
Rome 17
Mykolayiv 16
Norwalk 16
Kronberg 15
Milan 15
Ann Arbor 13
Hebei 13
Jiaxing 13
Nanchang 13
Tettnang 12
Woodbridge 12
Basel 11
Dublin 10
Leawood 10
Redwood City 9
Changsha 8
Nocera Inferiore 8
Bologna 7
Falls Church 7
Lappeenranta 7
Seattle 7
Tianjin 7
Bad Bellingen 6
Shenyang 6
Bari 5
Landshut 5
Marano Di Napoli 5
Ottaviano 5
Cambridge 4
Dallas 4
Hangzhou 4
Hanover 4
London 4
Salerno 4
Agropoli 3
Arezzo 3
Buenos Aires 3
Cagliari 3
Capranica 3
Fairfield 3
Florence 3
Genoa 3
Madrid 3
Marcon 3
Modugno 3
Monte San Savino 3
Redmond 3
San Lorenzo del Vallo 3
Abbiategrasso 2
Bad Durrheim 2
Brno 2
Capri 2
Casier 2
Council Bluffs 2
Dundalk 2
Gemona Del Friuli 2
Gijón 2
Giugliano In Campania 2
Granada 2
Indiana 2
Juiz de Fora 2
Kunming 2
Marrakesh 2
Masate 2
Medellín 2
Mīrpur 2
Paris 2
Philadelphia 2
Piacenza 2
Puebla City 2
Pune 2
Romainville 2
San Colombano Al Lambro 2
San Donà di Piave 2
San Pablo 2
Sant'Anastasia 2
Shrewsbury 2
Skopje 2
Treviso 2
Totale 2.082
Salva come PNG Salva come JPEG
Nome #
Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry 175
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 113
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 61
Developmental or Procedural Vena Cava Interruption and Venous Thromboembolism: A Review 54
Cyclic supplementation of 5-MTHF is effective for the correction of hyperhomocysteinemia 48
“A fast and accurate method for genotyping the Angiotensin-Converting Enzyme (ACE) I/D polymorphism” 47
Italian intersociety consensus on DOAC use in internal medicine 47
Budd-Chiari syndrome in a paroxysmal nocturnal hemoglobinuria patient with previous cerebral venous thrombosis 44
Long-lasting intestinal bleeding in an old patient with multiple mucosal vascular abnormalities and Glanzmann's thrombasthenia: 3-year pharmacological management. 42
Acute coronary syndrome and severe haemophilia: an unusual association with challenging treatment. 42
Plasma homocysteine and its determinants in diabetic retinopathy 41
Right-to-left shunt, atrial septal aneurysm and thrombophilia in patients with cryptogenic stroke or TIA vs. those with venous thrombo-embolism 41
Challenging report of cardiopulmonary bypass in 16th week pregnant patient with endoventricular mass 40
A fast and accurate method for genotyping the angiotensin-converting enzyme I/D polymorphism. 38
Cardiovascular disease and antiphospholipid syndrome: how to predict and how to treat? 38
Long-term prophylaxis with intermediate-purity factor VIII concentrate (Haemate P) in a patient with type 3 von Willebrand disease and recurrent gastrointestinal bleeding. 37
Acquired haemophilia a in the elderly: case reports. 37
Subclinical atherosclerosis in asymptomatic carriers of persistent antiphospholipid antibodies positivity: A cross-sectional study 37
Three-dimensional echocardiographic evaluation of the right ventricle in patients with uncomplicated systemic lupus erythematosus 36
Plasma homocysteine and microvascular complications in type 1 diabetes. 36
Ensuring medication adherence with direct oral anticoagulant drugs: lessons from adherence with vitamin K antagonists (VKAs). 36
The role of cardiovascular ultrasound in diagnosis and management of pulmonary embolism 36
Acquired Inhibitors of coagulation factors: Part I-acquired hemophilia a 35
The management of acute venous thromboembolism in clinical practice - study rationale and protocol of the European PREFER in VTE Registry 33
Anticancer Drug-Related Nonvalvular Atrial Fibrillation: Challenges in Management and Antithrombotic Strategies 33
Acquired Factor v Inhibitor after Coronavirus Disease 2019 (COVID-19) 33
Spontaneous Muscle Hematoma in Patients with COVID-19: A Systematic Literature Review with Description of an Additional Case Series 33
Diabetes mellitus and cardiovascular prevention: the role and the limitations of currently available antiplatelet drugs. 32
[Absence of an association of the D allele of the ACE gene with arterial pressure in mild-moderate essential arterial hypertension]. 32
Preventing postsurgical venous thromboembolism: pharmacological approaches 32
Position paper of the Italian Society of Internal Medicine (SIMI) on prophylaxis and treatment of venous thromboembolism in patients with cancer 32
Inferior Vena Cava Agenesis and Deep Vein Thrombosis in the Young: A Review of the Literature and Local Experience 31
Preventing Venous Thromboembolism in Ambulatory Cancer Patients: The ONKOTEV Study 31
Venous thromboembolism in covid-19 compared to non-covid-19 cohorts: A systematic review with meta-analysis 31
Longer-acting factor VIII to overcome limitations in haemophilia management the PEGylated liposomes formulation issue. 30
Risk factors and recurrent thrombotic episodes in patients with cerebral venous thrombosis 30
The hla variant rs6903608 is associated with disease onset and relapse of immune-mediated thrombotic thrombocytopenic purpura in caucasians 30
The infectious burden in atherothrombosis. 29
Pro12Ala substitution in the peroxisome proliferator-activated receptor-gamma2 is not associated with type 2 diabetes. 29
Noninvasive assessment of liver fibrosis in patients with chronic hepatitis C (and congenital bleeding disorders): where do we stand? 29
Pharmacological treatment and prevention of chronic venous ulcers: A review 29
The thromboembolic risk in giant cell arteritis: A critical review of the literature 28
ANMCO Position Paper: Long-term follow-up of patients with pulmonary thromboembolism 28
Atrial Fibrillation, Cancer and Echocardiography 28
Antithrombotic drugs for older subjects. Guidelines formulated jointly by the Italian Societies of Haemostasis and Thrombosis (SISET) and of Gerontology and Geriatrics (SIGG). 27
Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery 27
Speckle tracking echocardiography in patients with systemic lupus erythematosus: A meta-analysis 27
Molecular analysis and genotype-phenotype correlation in patients with antithrombin deficiency from Southern Italy. 26
Oxidative stress and plateletactivation in homozygous homocystinuria 25
Venous thromboembolism in the 3rd millennium: Challenges to the management of venous thromboembolism in the elderly 25
Eculizumab in pregnancy: a narrative overview 25
Fondaparinux in the initial and long-term treatment of venous thromboembolism 24
OXIDATIVE STRESS AND PLATELET ACTIVATION IN HOMOZYGOUS HOMOCYSTINURIA 24
Recombinant factor VIIa in a patient with Glanzmann's thrombasthenia undergoing gynecological surgery: open issues in light of successful treatment 24
Polyunsaturated fatty acids, thrombosis and vascular disease. 24
Treatment of hemophilia: a review of current advances and ongoing issues 24
Patent foramen ovale in patients with previous cerebral ischemic events: echocardiographic features and relationships with transcranial Doppler 24
Use of oral anticoagulant drugs in older patients with atrial fibrillation in internal medicine wards 24
Cardiac Manifestations of Antiphospholipid Syndrome: Clinical Presentation, Role of Cardiac Imaging, and Treatment Strategies 24
Arterial Thrombosis in Cancer Patients: An Update 24
[Venous thromboembolism in oncologic patients: guidelines for prevention and therapy and areas of uncertainty]. 23
[ANMCO Position paper: Recommendations for the follow-up of patients with pulmonary thromboembolism] 23
Appropriateness of oral anticoagulant therapy prescription and its associated factors in hospitalized older people with atrial fibrillation 23
Prophylaxis of venous thromboembolism in Internal Medicine Units: the RAMs issue 23
The association of adjusted Global AntiphosPholipid Syndrome Score (aGAPSS) with cardiovascular disease in subjects with antiphospholipid antibodies 23
First three months of anticoagulation for venous thromboembolism in non-cancer patients: LMWH VS. VKAs. Findings from the RIETE registry 22
Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: a review of the literature. 22
The challenge of diagnosing pulmonary embolism in children, pregnant women, and elderly patients: a descriptive review of the literature. 22
Identifying high-risk individuals for cardiovascular disease: similarities between venous and arterial thrombosis in perspective. A 2011 update. 22
Management of bleeding in acquired haemophilia A with recombinant activated factor VII: does one size fit all? A report of four cases. 22
Venous thromboembolism: which patients are truly at risk? 21
Heart Rate and Mortality in Patients With Acute Symptomatic Pulmonary Embolism 21
Asymptomatic and symptomatic deep venous thrombosis in hospitalized acutely ill medical patients: risk factors and therapeutic implications 20
Clinical Presentation and Short- and Long-term Outcomes in Patients With Isolated Distal Deep Vein Thrombosis vs Proximal Deep Vein Thrombosis in the RIETE Registry. 20
Validation of PLASMIC score in a cohort of patients with suspected thrombotic microangiopathy in an academic medical centre 20
A Rare Case of Tricuspid Valve Libman-Sacks Endocarditis in a Pregnant Woman with Primary Antiphospholipid Syndrome 20
Cardiovascular events in patients with antiphospholipid antibodies: strategies of prevention 20
Left ventricular diastolic abnormalities other than valvular heart disease in antiphospholipid syndrome: An echocardiographic study 20
Aspirin for preventing the recurrence of venous thromboembolism. 19
The first ambulatory screening on thromboembolism: a multicentre, cross-sectional, observational study on risk factors for venous thromboembolism. 19
HELLP syndrome and its relation with the antiphospholipid syndrome. 19
Current and evolving features in the clinical management of haemophilia. 19
Association between preexisting versus newly identified atrial fibrillation and outcomes of patients with acute pulmonary embolism 19
Cytomegalovirus-Associated Splanchnic Vein Thrombosis in Immunocompetent Patients: Two Case Reports and Literature Review 18
Efficacy and safety of direct oral anticoagulants in splanchnic vein thrombosis: a pooled analysis of literature studies 18
Paediatric arterial ischaemic stroke and cerebral sinovenous thrombosis: First report from the italian registry of pediatric thrombosis (R. I. T. I., Registro Italiano Trombosi Infantili) 18
Exploring newer cardioprotective strategies: ω-3 fatty acids in perspective. 18
Hypocalcemia and hypophosphatemia after treatment with zoledronic acid in a patient with AL amyloidosis 18
The impact of risk-adjusted heparin regimens on the outcome of patients with covid-19 infection. A prospective cohort study 18
Cancer-Associated Splanchnic Vein Thrombosis 18
Mesoglycan: clinical evidences for use in vascular diseases. 17
Recent venous thromboembolism amongst adult individuals attending general practitioner ambulatory (the FAST study): Prevalence of cardiovascular risk factors 17
Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation 16
Fatal events in cancer patients receiving anticoagulant therapy for venous thromboembolism 16
The "antiphospholipid triangle" in an asymptomatic patient: a case report. 16
Challenges in the prevention of venous thromboembolism in the elderly. 16
Cardiovascular risk factors and outcome in patients with retinal vein occlusion 16
Cardiovascular and Thromboembolic Diseases in Oncology: Novel Aspects and Revisited Issues 16
Simulation-Based Education for Physicians to Increase Oral Anticoagulants in Hospitalized Elderly Patients with Atrial Fibrillation 16
Corrigendum: The new Italian registry of infantile thrombosis (RITI): a reflection on its journey, challenges and pitfalls 15
Totale 2.971
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.811
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.811
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202098 0 0 0 0 6 1 4 5 2 29 35 16
2020/202197 16 6 7 14 12 14 6 1 10 3 8 0
2021/2022668 1 1 3 0 3 4 19 10 132 85 134 276
2022/2023895 145 66 13 29 57 65 0 173 178 106 52 11
2023/2024841 29 105 144 49 34 14 11 120 58 22 159 96
2024/2025757 236 323 24 67 107 0 0 0 0 0 0 0
Totale 3.809